ProLivRx versus TMS: mechanisms

How a new FDA approved device for difficult-to-treat depression engages the brain through the sensory nerves in part II of our interview with Linda Carpenter.

CME: Take the CME Post-Test for this Episode

Published On: 01/26/2026

Duration: 12 minutes, 33 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.